Physiological method of improving vision

A method for potentiating best visual acuity in a human which comprises topically administering to one or both eyes of the human an amount of a composition sufficient to inhibit acetylcholine esterase activity in the eye of the patient.

A method of treating an eye disorder of a human patient which comprises topically administering to both eyes of the human patient or to an eye affected with said disorder, an amount of (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate containing composition sufficient to provide a therapeutic benefit, wherein the eye disorder is color vision blindness, ocular hypertension, progression of myopia, Strabismus or pupil dilation and wherein the composition has (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate content of 0.001% to about 0.25%.

A method of treating an eye disorder of a patient which comprises topically administering to both eyes of the human patient or to an eye affected with said disorder, an amount of (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate containing composition sufficient to provide a therapeutic benefit, wherein the eye disorder is color vision blindness, ocular hypertension, progression of myopia, Strabismus or pupil dilation and wherein the composition has (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate content of 0.015% to about 0.03%

A method of achieving neuroprotection in an eye of a human patient, the method comprising topically administering to the eye, an amount of (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate containing composition sufficient to provide a therapeutic benefit to achieve the neuroprotection in the human patient, wherein the composition has (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate content of about 0.015% wherein said composition is administered at bedtime.

A method of treating d a human patient suffering from progressive myopia, the method comprising topically administering to an eye affected with said myopia, an amount of a acetylcholine esterase inhibitor containing composition sufficient to provide a therapeutic benefit.

A method of treating a human patient suffering from an eye disease, the method comprising topically administering to both eyes of the human patient or to an eye affected with said disorder, an amount of (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate containing composition sufficient to provide a therapeutic benefit, wherein the eye disorder is color vision blindness, ocular hypertension, progression of myopia, Strabismus or pupil dilation and wherein the composition has (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate content of 0.015% to about 0.03% and wherein said composition is administered at bedtime.